Skip to main content
. 2024 Oct 10;12(10):2050. doi: 10.3390/microorganisms12102050

Figure 1.

Figure 1

Graphical representation of achieving SVR4 and SVR12; sensitivity, specificity, PPV and NPV of SVR4 required for achieving SVR12 by genotypes according to the treatment modality; G/P—glecaprevir/pibrentasvir; SOF/VEL—sofosbuvir/velpatasvir +/− ribavirin.